Alta Schutte

Last updated

Aletta E. Schutte
Born (1977-07-08) 8 July 1977 (age 46)
Klerksdorp, South Africa
NationalitySouth African
Alma mater Potchefstroom University for Christian Higher Education
Occupation(s)Hypertension and blood pressure expert
AwardsHarriet Dustan Award of Research Excellence, AHA Council on Hypertension , Peter Sleight Excellence Award in Hypertension Clinical Research, World Hypertension League
Website https://research.unsw.edu.au/people/professor-alta-schutte

Aletta E. "Alta" Schutte is a South African hypertension and heart disease expert based in Sydney, Australia. She is a SHARP Professor and Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine at the University of New South Wales in Sydney, with a joint appointment as Professorial Fellow at the George Institute for Global Health. Until 2019 she was the Director of the Hypertension in Africa Research Team (HART), South African Research Chair (SARChI) and Director of the Medical Research Council Extramural Unit for Hypertension and Cardiovascular Disease at the North-West University in South Africa. She has fulfilled several leadership roles, including the President of the Southern African Hypertension Society, and President of the International Society of Hypertension, Secretary of the Australian Cardiovascular Alliance, and is the Co-Chair of the National Hypertension Taskforce of Australia.

Contents

She did her Doctorate at the Potchefstroom University for Christian Higher Education in Cardiovascular Physiology. [1] [2] [3] [4]

Career and Research

Schutte worked at the North-West University in South Africa from 2001 to 2019. When Schutte took on her former role where she was the South African Research Chair in the Early Detection and Prevention of Cardiovascular Disease in Africa, her primary focus point for her research was to detect early markers for the detection and prevention of hypertension and cardiovascular disease in the African community. [5]

Since moving to Australia in 2020, she has taken on leadership roles to improve blood pressure control in the country and internationally, and has been successful as Chief Investigator with several funding schemes (e.g Investigator Leadership Grant from the National Health and Medical Research Council of Australia, and clinical trial grants from the Medical Research Future Fund of Australia).

In 2023 she was listed by The Australian as the Leading Australian Researcher in Vascular Medicine. [6]

Related Research Articles

Essential hypertension is the form of hypertension that by definition has no identifiable secondary cause. It is the most common type affecting 85% of those with high blood pressure. The remaining 15% is accounted for by various causes of secondary hypertension. Primary hypertension tends to be familial and is likely to be the consequence of an interaction between environmental and genetic factors. Prevalence of essential hypertension increases with age, and individuals with relatively high blood pressure at younger ages are at increased risk for the subsequent development of hypertension. Hypertension can increase the risk of cerebral, cardiac, and renal events.

<span class="mw-page-title-main">Baker Heart and Diabetes Institute</span>

The Baker Heart and Diabetes Institute, commonly known as the Baker Institute, is an Australian independent medical research institute headquartered in Melbourne, Victoria. Established in 1926, the institute is one of Australia's oldest medical research organisations with a historical focus on cardiovascular disease. In 2008, it became the country's first medical research institute to target diabetes, heart disease, obesity and their complications at the basic, clinical and population health levels.

Marc Twagirumukiza is a Belgian senior physician and a senior clinical researcher in the fields of clinical pharmacology, cardiovascular and hypertension research. He is particularly oriented in data sciences and clinical drug development. He is also chair of the World Wide Web Consortium Healthcare Schema Vocabulary Community Group.

John David Spence is a Canadian medical doctor, medical researcher and Professor Emeritus at the University of Western Ontario. He is affiliated with the University of Western Ontario and the Robarts Research Institute, one of Canada's leading medical research organizations. Before his retirement from clinical practice in July 2022, he was also affiliated with the London Health Sciences Centre's University Hospital. He is a recognized expert in stroke prevention and stroke prevention research, with more than 600 peer-reviewed publications since 1970. He delivered more than 600 lectures on stroke prevention in 42 countries. In 2015, he received the Research Excellence Award from the Canadian Society for Atherosclerosis, Thrombosis and Vascular Biology. In 2019, he was appointed a Member of the Order of Canada, and in 2020 he received the William Feinberg Award from the American Heart Association for excellence in clinical stroke research.

John Eric Deanfield is a British professor of cardiology and past Olympic fencer.

Stephen William MacMahon AO DSc FAA FMediSci FAHMS FACC is a British-Australian academic medical researcher, healthcare entrepreneur and founder of The George Institute for Global Health. He holds professorial academic appointments in medicine at UNSW Sydney and Imperial College London.

The Heart Research Institute (HRI) is a not-for-profit research facility, originally based in Camperdown, New South Wales, Australia and currently based in Newtown, New South Wales.

Professor Peter Sleight M.D.(Cantab.), D.M. (Oxon.) FRCP FACC was a distinguished and internationally renowned research cardiologist and an Honorary Consultant Physician at the John Radcliffe Hospital in Oxford and the Oxford University Hospitals NHS Foundation Trust. Sleight was Emeritus Field Marshal Alexander Professor of Cardiovascular Medicine at the University of Oxford and an Emeritus Fellow of Exeter College, Oxford.

<span class="mw-page-title-main">Jason X.-J. Yuan</span> American physician scientist (born 1963)

Jason X.-J. Yuan is an American physician scientist whose research interests center on pulmonary vascular pathobiology and pulmonary hypertension. His current research is primarily focused on the pathogenic mechanisms of pulmonary vascular diseases and right heart failure.

Norman R.C. Campbell is a Professor Emeritus of the University of Calgary, where he served as professor of Medicine, Community Health Sciences and Physiology and Pharmacology and as a member of the O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta. Dr Campbell continues as a Senior consultant to Resolve To Save Lives (RTSL), a temporary advisor to the World Bank to provide advice for hypertension control in Samoa and Cambodia, a consultant to the Pan American Health Organization Hearts in the Americas Initiative and a consultant to the for hypertension control in Mongolia.

Rhian M. Touyz Koppel MBBCh, MSc (Med), PhD, FRCP, FRSE, FMedSci, FCAHS is a Canadian medical researcher. She is currently serving as the Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre in Montreal, Canada, since 2021. A clinician scientist, her research primarily focuses on hypertension and cardiovascular disease.

Vlado Perkovic is an Australian renal physician and researcher who is the Provost at the University of New South Wales, Sydney, having previously been Dean of Medicine & Health at that University between 2019 and 2023.

Suzanne Oparil is a clinical cardiologist and Distinguished Professor of Medicine, Professor of Cell, Developmental, and Integrative Biology. She is the Section Chief of Vascular Biology and Hypertension and the Director of the Vascular Biology and Hypertension Program of the Division of Cardiovascular Disease at the University of Alabama-Birmingham (UAB) Medical School.

<span class="mw-page-title-main">Harriet P. Dustan</span> American physician

Harriet Pearson Dustan (1920–1999) was an American physician who is known for her pioneering contributions to effective detection and treatment of hypertension. She was the first woman to serve on the Board of Governors of the American Board of Internal Medicine.

Cheryl Ann Marie Anderson is an American epidemiologist. Anderson is a professor at and founding Dean of the University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science. Anderson's research focus is on nutrition and chronic disease prevention in under-served human populations.

Nishi Chaturvedi is a Professor of Clinical Epidemiology at University College London. Her research considers how ethnicity and lifestyle impact people's risk factors for disease. During the COVID-19 pandemic, Chaturvedi explained that the increased mortality rate for people from black and minority ethnic backgrounds was due to societal inequality and how this intersects with healthcare.

Michelle Asha Albert is an American physician who is the Walter A. Haas Lucie-Stern Endowed Chair in Cardiology and professor of medicine at the University of California, San Francisco. Albert is director of the UCSF Center for the Study of Adversity and Cardiovascular Disease. She is president of the American Heart Association. She served as the president of the Association of Black Cardiologists in 2020–2022 and as president of the Association of University Cardiologists (2021–2022). Albert is an elected member of the National Academy of Medicine, the American Society of Clinical Investigators and the Association of American Physicians.

<span class="mw-page-title-main">Jason C. Kovacic</span> Australian cardiologist and physician

Jason C. Kovacic is an Australian-born cardiologist and physician-scientist; the Robert Graham Chair and Professor of Medicine, University of New South Wales; Executive Director of the Victor Chang Cardiac Research Institute in Sydney, Australia; and Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai, New York.

Anne Monique Nuyt is a Canadian paediatrician who is Professor of Neonatology and Canada Research Chair in Prematurity and Developmental Origins of Cardiovascular Health and Diseases at the Université de Montréal. Her research considers how perinatal oxidative stress can alter the structural development and function of the cardiovascular system.

Gemma Alexandra Figtree is an Interventional Cardiologist at Royal North Shore Hospital, Professor in Medicine at the University of Sydney, chair of the Federal Government's 10-year Mission for Cardiovascular Health, and co-leader of the Cardiovascular Theme for Sydney Health Partners.

References

  1. ↑ "Professor Alta Schutte". University of New South Wales . Retrieved 13 September 2021.
  2. ↑ "These powerful African scientists are changing the world". One. 9 February 2018. Retrieved 13 September 2021.
  3. ↑ "Professor Alta Schutte". The George Institute. Retrieved 13 September 2021.
  4. ↑ "George Clinical Scientific Leadership Adds Hypertension and CV Researcher Prof Alta Schutte". Cardiology2. 21 August 2020. Archived from the original on 13 September 2021. Retrieved 13 September 2021.
  5. ↑ "Alta Schutte, PhD – George Clinical" . Retrieved 28 February 2022.
  6. ↑ "We delve deep into the data to reveal excellence" . Retrieved 15 November 2023.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.